Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Understanding which risk dominates can guide your allocation decisions. This comparison highlights when inflation worry or market dips matter more.
28,524 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Investors are weighing value exposure against high-quality income. This piece analyzes why SCHD may outperform VTV on...
Despite the everyday label of 'dull,' transportation stocks move goods and markets. In 2026, two names shine with str...
Uncover five key quotes from AMD's earnings call and what they could mean for the stock in 2026. Learn how to transla...
Imagine an AI that studies your crypto habits during idle moments and preps the next move you might take. This articl...
A blowout quarter sent AeroVironment stock soaring, but the bigger question for investors is whether the drone boom h...
When a market giant bets on housing, investors notice. This article dives into Berkshire Hathaway's $6.8 billion move...
A $500 starter can set you up for long-term growth. This guide weighs the best invest $500 right now, comparing low-c...
Two giants in the U.S. cannabis space face off for investors: Green Thumb Industries and Curaleaf. This guide breaks ...
Markets watch the debt path as deficits and entitlement costs rise. A budget watchdog warns that the current calm cou...
Oil prices stay elevated as the u.s. energy chief signals the Iran conflict may extend for weeks. Officials say short...
Late-career savers confront a hard truth: retirement funding offers fewer options than college savings. Experts say c...